What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Immune system, Immunology, Immune checkpoint, Cancer research and Cancer.
Immune checkpoint is a subfield of Blockade that Robert A. Anders investigates.
His Blockade study integrates concerns from other disciplines, such as T cell, Checkpoint Blockade Immunotherapy and DNA mismatch repair.
His Cancer research study combines topics from a wide range of disciplines, such as Mutation and Exome sequencing.
His study in Cancer is interdisciplinary in nature, drawing from both Melanoma and Oncology.
His Nivolumab research is multidisciplinary, incorporating elements of Colorectal cancer and Ipilimumab.
His most cited work include:
- Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. (8133 citations)
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency (4640 citations)
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade (2396 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Internal medicine, Pathology, Cancer and Immunology.
His studies deal with areas such as Immune checkpoint, Pancreatic cancer, Tumor microenvironment, Immune system and DNA mismatch repair as well as Cancer research.
His Immune checkpoint study contributes to a more complete understanding of Blockade.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology, Endocrinology and Oncology.
His work in Pathology tackles topics such as Hepatocellular carcinoma which are related to areas like Radiology.
His Cancer study incorporates themes from Surgery and Melanoma.
He most often published in these fields:
- Cancer research (29.29%)
- Internal medicine (28.96%)
- Pathology (22.56%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (29.29%)
- Internal medicine (28.96%)
- Immunotherapy (9.76%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Internal medicine, Immunotherapy, Oncology and Tumor microenvironment.
His research in Cancer research intersects with topics in Immune checkpoint, CD8, Immune system, DNA mismatch repair and Cytotoxic T cell.
His research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Biopsy.
His Immunotherapy research integrates issues from Blockade, Colorectal cancer and Melanoma.
The Oncology study combines topics in areas such as Cancer, Clinical endpoint, Clinical trial, GVAX and Nivolumab.
In his work, Combination therapy is strongly intertwined with Cabozantinib, which is a subfield of Nivolumab.
Between 2017 and 2021, his most popular works were:
- Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria (314 citations)
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression (201 citations)
- Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis (128 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Internal medicine, Cancer research, Oncology, Immunotherapy and Immune system.
Many of his research projects under Internal medicine are closely connected to Plasmacytosis with Plasmacytosis, tying the diverse disciplines of science together.
The study incorporates disciplines such as Tumor microenvironment and CD8 in addition to Cancer research.
His Oncology research incorporates themes from Pembrolizumab, Cancer, Clinical trial, GVAX and Cyclophosphamide.
His work carried out in the field of Immunotherapy brings together such families of science as Blockade, Colorectal cancer and Melanoma.
His work on Immune checkpoint as part of general Blockade research is frequently linked to Microsatellite instability, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
